Henan Lingrui Pharmaceutical Co., Ltd. (SHSE: 600285)
Health Care · Pharmaceuticals · CN
CN¥19.58
+0.20% today · -17.3% 1Y
Henan Lingrui Pharmaceutical Co., Ltd. (SHSE: 600285) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.65B and employs 2,789 people.
Over the last twelve months the share price has lost 17.3%, trading between 19.00 and 24.75.
Tweenvest scores Henan Lingrui Pharmaceutical Co., Ltd. across four factors: quality 86/100, value 75/100, growth 56/100, dividend 90/100. Its strongest factor is dividend.
600285 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.65B
- Revenue (TTM)
- $574.46M
- P/E
- 14.24
- EPS
- 1.37
- Dividend yield
- 5.63%
- Beta (5Y)
- -0.00
- 52-week high
- CN¥24.75
- 52-week low
- CN¥19.00
- Avg volume (3M)
- —
- Shares outstanding
- 567.12M
- Employees
- 2,789
- Next earnings
- —
About Henan Lingrui Pharmaceutical Co., Ltd.
Established in 1992 and headquartered in Xinyang, China, Henan Lingrui Pharmaceutical Co., Ltd. specializes in the production and distribution of pharmaceutical products throughout the Chinese market. The company offers a broad catalog of approximately 100 different medications, provided in ten distinct dosage formats such as adhesive plasters, tablets, capsules, granules, and tinctures. Prominent items in their product line include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, and Shenqi Hypoglycemic capsules.
- ISIN
- CNE000001501
- Founded
- 1992
- Listed since
- Oct 18, 2000
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.